Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab, ipilimumab, radiation, and influenza vaccine in metastatic pancreatic cancer
2021-003931-27Phase 2Terminated
- Sponsor
- Herlev & Gentofte Hospital
- Start
- Jul 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nivolumab, ipilimumab and influenza vaccine in pancreatic cancer (PC), sponsored by Herlev & Gentofte Hospital. Primary endpoint: Objective response rate. Started Jul 2021; status: terminated.
02
Drugs
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on 2021-003931-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003931-27.